Policy Blog: 2025 Colorado Bills Signed into Law 

Of the 26 bills relevant to Colorado’s life sciences ecosystem and the patients it serves that CBSA tracked during Colorado’s 2025 legislative session, Governor Polis has now signed into law all 22 bi...

Learn More

Policy Blog: Colorado’s PDAB Begins First UPL Rulemaking 

On May 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) became the first PDAB in the country to move toward capping the price of a drug by holding an upper payment limit (UPL) ru...

Learn More

Policy Blog: Colorado’s 2025 Legislative Session Wraps Up  

Colorado’s 2025 legislative session, the First Regular Session of the 75th General Assembly, concluded on May 7, the 120th day of session. During the final weeks of this challenging session, the Color...

Learn More

Policy + Advocacy – Final Hours of 2025 Legislative Session 

The Colorado General Assembly adjourns tonight, Wednesday, May 7, at midnight. Throughout the challenging 120-day session, CBSA’s Policy + Advocacy team worked tirelessly to advocate for policies that...

Learn More

Weekly Policy Blog: CBSA Advocates on Federal Issues During the 2025 BIO Fly-In 

Last week, Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, joined state leaders as part of the Biotechnology Innovation Organization (BIO) Council...

Learn More

Weekly Policy Blog: CBSA’s Advocacy on 340B Continues as Two Bills Pass Senate 

Colorado’s legislature is considering two bills related to the federal 340B Drug Pricing Program and both bills are now advancing to the House after passing out of the Senate today.   Colora...

Learn More

Weekly Policy Blog: CBSA’s 2024 Policy + Advocacy Report 

Colorado BioScience Association (CBSA) has released its 2024 CBSA Policy + Advocacy Report, which summarizes CBSA’s engagement during the Colorado legislative session, the regulatory processes to...

Learn More

Start of the 2025 Colorado Legislative Session 

Colorado’s 2025 legislative session kicked off on Wednesday, January 8th, and will continue for 120 days until May 7th. Key issues that are top of mind for the Colorado life sciences ecosystem include...

Learn More

Weekly Policy Blog: Questions Remain Around Expected Impact of Trump’s Nominees 

As President-elect Donald Trump fills out his administration’s leadership ranks, the life sciences ecosystem is watching closely. Trump's nominees could significantly influence the landscape of health...

Learn More

Weekly Policy Blog: Event Educates on 340B “Abuse and Misuse” 

Last week, CBSA co-hosted an educational event for legislators and other stakeholders in partnership with PhRMA and Colorado Politics. The event featured a panel discussion that addressed the drivers...

Learn More